A model of modified meta -iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue RSC Advances Année : 2021

A model of modified meta -iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment

Résumé

Iodine-131 meta-iodobenzylguanidine (131I-mIBG) has been utilized as a standard treatment to minimize adverse side effects by targeting therapies to bind to the norepinephrine transporter (NET) expressed on 90% of neuroblastoma cells. However, only a minority of patients who receive 131I-mIBG radiotherapy have clinical responses, and these are usually not curative. In this study, novel ligand-conjugated gold nanoparticles (GNPs) based on mIBG were synthesized and evaluated biologically with neuroblastoma cells in vitro. To induce specific internalization to the tumor cells and utilize it as a model for radioenhancement, 127I-modified mIBG was successfully synthesized and grafted covalently to the surface of carboxylated PEG-GNPs. 49.28% of the novel mIBG derivative was grafted on carboxylated PEG-GNPs. The particles were stable and not toxic to the normal fibroblast cell line, L929, even at the highest concentration tested (1013 NPs per mL) at 24, 48, and 72 h. Moreover, the cellular uptake of the model was decreased significantly in the presence of a NET inhibitor, suggesting that there was specific internalization into neuroblastoma cells line (SH-SY5Y) via the NET. Therefore, this model provides useful guidance toward the design of gold nanomaterials to enhance the efficiency of 131I-mIBG treatment in neuroblastoma patients. However, the investigation of radio-therapeutic efficiency after radioisotope 131I substitution will be further conducted in a radiation safety laboratory using an animal model.
Fichier principal
Vignette du fichier
2021-RSC-mIBG final 1307202.pdf (1.38 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03318001 , version 1 (27-10-2021)

Identifiants

Citer

Kween Saimuang, Khomson Suttisintong, Narongpol Kaewchangwat, Eknarin Thanayupong, Yodsathorn Wongngam, et al.. A model of modified meta -iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment. RSC Advances, 2021, 11 (41), pp.25199-25206. ⟨10.1039/d1ra04054e⟩. ⟨hal-03318001⟩
25 Consultations
65 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More